Clinical Trial Update: Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pramipexole to placebo in restless legs syndrome has completed, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED